Candidemic complications in patients with intravascular catheters colonized with Candida species: An indication for preemptive antifungal therapy?

International Journal of Infectious Diseases

Volumn 15, Issue 7, 2011, Pages

  Leenders, N H J ^a   Oosterheert, J J ^a   Ekkelenkamp, M B ^a   De Lange, D W ^a   Hoepelman, A I M ^a   Peters, E J G ^b  

^a UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^b VU UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

Bloodstream infection; Candida spp; Candidemia; Intravascular catheter

Indexed keywords

AMPHOTERICIN B; ANTIFUNGAL AGENT; FLUCONAZOLE;

ABDOMINAL SURGERY; ADOLESCENT; ADULT; AGED; ARTICLE; BLOOD CULTURE; CANDIDA; CANDIDEMIA; CHILD; CONTROLLED STUDY; CULTURE MEDIUM; FEMALE; FUNGAL COLONIZATION; HUMAN; INTRAVASCULAR CATHETER; MAJOR CLINICAL STUDY; MALE; MORTALITY; OUTCOME ASSESSMENT; RETROSPECTIVE STUDY; RISK FACTOR; SCHOOL CHILD; TREATMENT INDICATION;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ANTIFUNGAL AGENTS; CANDIDA; CANDIDEMIA; CANDIDIASIS, INVASIVE; CASE-CONTROL STUDIES; CATHETERIZATION, CENTRAL VENOUS; CATHETERS, INDWELLING; CHILD; CHILD, PRESCHOOL; CULTURE MEDIA; HOSPITAL MORTALITY; HUMANS; INFANT; INFANT, NEWBORN; MALE; MIDDLE AGED; RETROSPECTIVE STUDIES; RISK FACTORS; YOUNG ADULT;

EID: 79959245442     PISSN: 12019712     EISSN: 18783511     Source Type: Journal    
DOI: 10.1016/j.ijid.2011.03.009     Document Type: Article

References (27)

1. Pfaller M.A., Diekema D.J., Jones R.N., Sader H.S., Fluit A.C., Hollis R.J., Messer SA International surveillance of bloodstream infections due to Candida species: frequency of occurrence and in vitro susceptibilities to fluconazole, ravuconazole, and voriconazole of isolates collected from 1997 through 1999 in the SENTRY antimicrobial surveillance program. J Clin Microbiol 2001, 39:3254-3259. SENTRY Participant Group.
2. Wisplinghoff H., Bischoff T., Tallent S.M., Seifert H., Wenzel R.P., Edmond M.B. Nosocomial bloodstream infections in US hospitals: analysis of 24,179 cases from a prospective nationwide surveillance study. Clin Infect Dis 2004, 39:309-317.
3. Mean M., Marchetti O., Calandra T. Bench-to-bedside review: Candida infections in the intensive care unit. Crit Care 2008, 12:204.
4. Diekema D.J., Messer S.A., Brueggemann A.B., Coffman S.L., Doern G.V., Herwaldt L.A., Pfaller M.A. Epidemiology of candidemia: 3-year results from the emerging infections and the epidemiology of Iowa organisms study. J Clin Microbiol 2002, 40:1298-1302.
5. Kao A.S., Brandt M.E., Pruitt W.R., Conn L.A., Perkins B.A., Stephens D.S., et al. The epidemiology of candidemia in two United States cities: results of a population-based active surveillance. Clin Infect Dis 1999, 29:1164-1170.
6. Tortorano A.M., Kibbler C., Peman J., Bernhardt H., Klingspor L., Grillot R. Candidaemia in Europe: epidemiology and resistance. Int J Antimicrob Agents 2006, 27:359-366.
7. Blot S.I., Vandewoude K.H., Hoste E.A., Colardyn F.A. Effects of nosocomial candidemia on outcomes of critically ill patients. Am J Med 2002, 113:480-485.
8. Garey K.W., Rege M., Pai M.P., Mingo D.E., Suda K.J., Turpin R.S., Bearden D.T. Time to initiation of fluconazole therapy impacts mortality in patients with candidemia: a multi-institutional study. Clin Infect Dis 2006, 43:25-31.
9. Morrell M., Fraser V.J., Kollef M.H. Delaying the empiric treatment of Candida bloodstream infection until positive blood culture results are obtained: a potential risk factor for hospital mortality. Antimicrob Agents Chemother 2005, 49:3640-3645.
10. Parkins M.D., Sabuda D.M., Elsayed S., Laupland K.B. Adequacy of empirical antifungal therapy and effect on outcome among patients with invasive Candida species infections. J Antimicrob Chemother 2007, 60:613-618.
11. Leon C., Ruiz-Santana S., Saavedra P., Almirante B., Nolla-Salas J., Alvarez-Lerma F., et al. A bedside scoring system ('Candida score') for early antifungal treatment in nonneutropenic critically ill patients with Candida colonization. Crit Care Med 2006, 34:730-737. EPCAN Study Group.
12. Leon C., Ruiz-Santana S., Saavedra P., Galván B., Blanco A., Castro C., et al. Usefulness of the 'Candida score' for discriminating between Candida colonization and invasive candidiasis in non-neutropenic critically ill patients: a prospective multicenter study. Crit Care Med 2009, 37:1624-1633. Cava Study Group.
13. Nolla-Salas J., Sitges-Serra A., León-Gil C., Martínez-González J., León-Regidor M.A., Ibáñez-Lucía P., Torres-Rodríguez J.M. Candidemia in non-neutropenic critically ill patients: analysis of prognostic factors and assessment of systemic antifungal therapy. Study Group of Fungal Infection in the ICU. Intensive Care Med 1997, 23:23-30.
14. Ostrosky-Zeichner L., Sable C., Sobel J., Alexander B.D., Donowitz G., Kan V., et al. Multicenter retrospective development and validation of a clinical prediction rule for nosocomial invasive candidiasis in the intensive care setting. Eur J Clin Microbiol Infect Dis 2007, 26:271-276.
15. Richet H., Roux P., Des Champs C., Esnault Y., Andremont A. Candidemia in French hospitals: incidence rates and characteristics. Clin Microbiol Infect 2002, 8:405-412.
16. Mermel L.A., Allon M., Bouza E., Craven D.E., Flynn P., O'Grady N.P., et al. Clinical practice guidelines for the diagnosis and management of intravascular catheter-related infection: 2009 update by the Infectious Diseases Society of America. Clin Infect Dis 2009, 49:1-45.
17. Mermel L.A., Farr B.M., Sherertz R.J., Raad I.I., O'Grady N., Harris J.S., Craven D.E. Infectious Diseases Society of America; American College of Critical Care Medicine; Society for Healthcare Epidemiology of America. Guidelines for the management of intravascular catheter-related infections. Clin Infect Dis 2001, 32:1249-1272.
18. Ekkelenkamp M.B., van der Bruggen T., van de Vijver D.A., Wolfs T.F., Bonten M.J. Bacteremic complications of intravascular catheters colonized with Staphylococcus aureus. Clin Infect Dis 2008, 46:114-118.
19. Ruhe J.J., Menon A. Clinical significance of isolated Staphylococcus aureus central venous catheter tip cultures. Clin Microbiol Infect 2006, 12:933-936.
20. Perez-Parra A., Munoz P., Guinea J., Martin-Rabadan P., Guembe M., Bouza E. Is Candida colonization of central vascular catheters in non-candidemic, non-neutropenic patients an indication for antifungals?. Intensive Care Med 2009, 35:707-712.
21. de Smet A.M., Kluytmans J.A., Cooper B.S., Mascini E.M., Benus R.F., van der Werf T.S., et al. Decontamination of the digestive tract and oropharynx in ICU patients. N Engl J Med 2009, 360:20-31.
22. Ascioglu S., Rex J.H., de Pauw B., Bennett J.E., Bille J., Crokaert F., et al. Invasive Fungal Infections Cooperative Group of the European Organization for Research and Treatment of Cancer; Mycoses Study Group of the National Institute of Allergy and Infectious Diseases. Defining opportunistic invasive fungal infections in immunocompromised patients with cancer and hematopoietic stem cell transplants: an international consensus. Clin Infect Dis 2002, 34:7-14.
23. Bone R.C., Balk R.A., Cerra F.B., Dellinger R.P., Fein A.M., Knaus W.A., et al. Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. The ACCP/SCCM Consensus Conference Committee. American College of Chest Physicians/Society of Critical Care Medicine. Chest 1992, 101:1644-1655.
24. Pappas P.G., Kauffman C.A., Andes D., Benjamin D.K., Calandra T.F., Edwards J.E., et al. Clinical practice guidelines for the management of candidiasis: 2009 update by the Infectious Diseases Society of America. Clin Infect Dis 2009, 48:503-535.
25. Maki D.G., Weise C.E., Sarafin H.W. A semiquantitative culture method for identifying intravenous-catheter-related infection. N Engl J Med 1977, 296:1305-1309.
26. Berenguer J., Buck M., Witebsky F., Stock F., Pizzo P.A., Walsh T.J. Lysis-centrifugation blood cultures in the detection of tissue-proven invasive candidiasis. Disseminated versus single-organ infection. Diagn Microbiol Infect Dis 1993, 17:103-109.
27. Pittet D., Monod M., Suter P.M., Frenk E., Auckenthaler R. Candida colonization and subsequent infections in critically ill surgical patients. Ann Surg 1994, 220:751-758.